Renin-Angiotensin — Revision Notes

⚡ 30-Second Revision

Renin: — Enzyme from JGA (kidney). Stimulated by $downarrow$ BP, $downarrow$ blood volume, $downarrow Na^+$ to macula densa, sympathetic. Converts Angiotensinogen $ightarrow$ Angiotensin I.
Angiotensinogen: — Liver protein, precursor.
Angiotensin I: — Inactive decapeptide.
ACE (Angiotensin-Converting Enzyme): — Primarily lungs. Converts Angiotensin I $ightarrow$ Angiotensin II. Inactivates Bradykinin.
Angiotensin II: — Active octapeptide. Potent vasoconstrictor. Stimulates Aldosterone, ADH, Thirst, Sympathetic activity. Increases $Na^+$ reabsorption.
Aldosterone: — Adrenal cortex. Stimulated by Angiotensin II. Acts on distal tubule/collecting duct. Increases $Na^+$ & water reabsorption, $K^+$ excretion. Increases blood volume.
Overall Goal: — Increase BP and blood volume.

2-Minute Revision

The Renin-Angiotensin System (RAS) is a critical hormonal cascade for regulating blood pressure and fluid balance. It begins in the kidneys when juxtaglomerular (JG) cells release renin in response to low blood pressure, low blood volume, or low sodium delivery to the macula densa.

Renin then acts on angiotensinogen (from the liver) to form Angiotensin I. This inactive form is converted by Angiotensin-Converting Enzyme (ACE), mainly in the lungs, into the highly active Angiotensin II.

Angiotensin II is a powerful vasoconstrictor, directly raising blood pressure. It also stimulates the adrenal glands to release aldosterone, which promotes sodium and water reabsorption in the kidneys, further increasing blood volume.

Additionally, Angiotensin II stimulates ADH release and thirst. This coordinated response elevates blood pressure and restores fluid volume, with negative feedback mechanisms ensuring proper regulation.

Medications targeting this system, like ACE inhibitors, are vital for treating hypertension.

5-Minute Revision

The Renin-Angiotensin System (RAS) is a complex neurohormonal pathway essential for maintaining cardiovascular homeostasis, particularly in response to hypotension or hypovolemia. The cascade initiates with the release of renin, a proteolytic enzyme, from the juxtaglomerular (JG) cells of the kidney.

Renin secretion is triggered by three main stimuli: a decrease in renal perfusion pressure (sensed by JG cells), a reduction in $Na^+$ delivery to the macula densa (sensed by macula densa cells), and sympathetic nervous system activation.

Once released, renin acts on angiotensinogen, an $\alpha_2$-globulin synthesized by the liver, converting it into the decapeptide Angiotensin I. Angiotensin I is biologically inactive but serves as a precursor.

As Angiotensin I circulates, it encounters Angiotensin-Converting Enzyme (ACE), predominantly found on the endothelial cells of the pulmonary circulation. ACE cleaves Angiotensin I to form the highly potent octapeptide Angiotensin II.

Angiotensin II is the primary effector of the RAS, exerting multiple actions: it is a powerful vasoconstrictor, directly increasing systemic vascular resistance and blood pressure; it stimulates the adrenal cortex to release aldosterone, which promotes $Na^+$ and water reabsorption in the renal distal tubules and collecting ducts, thereby increasing blood volume; it stimulates the posterior pituitary to release Antidiuretic Hormone (ADH), further enhancing water reabsorption; it acts on the brain to stimulate thirst; and it enhances sympathetic nervous system activity.

The overall effect is a coordinated increase in blood pressure and extracellular fluid volume. The system is regulated by negative feedback, where increased blood pressure and volume reduce the initial stimuli for renin release.

Clinically, drugs like ACE inhibitors and Angiotensin Receptor Blockers (ARBs) target this system to manage hypertension and heart failure.

Prelims Revision Notes

The Renin-Angiotensin System (RAS) is a crucial hormonal cascade for blood pressure and fluid regulation.

1. Renin Release:

Source: — Juxtaglomerular (JG) cells of the kidney (part of JGA).
Stimuli for Release:

* Decreased blood pressure in afferent arteriole (JG cells act as baroreceptors). * Decreased $Na^+$ concentration in tubular fluid at macula densa (sensed by macula densa cells). * Sympathetic nervous system activation ($\beta_1$-adrenergic receptors on JG cells).

2. Cascade Steps:

Renin acts on Angiotensinogen (liver-produced $\alpha_2$-globulin) to form Angiotensin I (decapeptide, inactive).
Angiotensin-Converting Enzyme (ACE) — (primarily in lung endothelium) converts Angiotensin I to Angiotensin II (octapeptide, highly active).
ACE also inactivates Bradykinin (a vasodilator).

3. Effects of Angiotensin II:

Potent Vasoconstriction: — Directly constricts systemic arterioles, increasing Total Peripheral Resistance (TPR) and blood pressure.
Aldosterone Secretion: — Stimulates adrenal cortex (zona glomerulosa) to release Aldosterone.
ADH Secretion: — Stimulates posterior pituitary to release Antidiuretic Hormone (ADH/Vasopressin).
Thirst Stimulation: — Acts on brain centers to increase thirst.
Sympathetic Activity: — Enhances norepinephrine release and inhibits its reuptake, increasing sympathetic tone.
Renal Effects: — Increases $Na^+$ reabsorption in proximal tubule; constricts efferent arteriole (maintains GFR).

4. Aldosterone Action:

Source: — Adrenal cortex (zona glomerulosa).
Stimulus: — Primarily Angiotensin II.
Target: — Principal cells of distal convoluted tubule and collecting duct.
Effect: — Increases $Na^+$ reabsorption, $K^+$ secretion, and $H^+$ secretion. Water follows $Na^+$, increasing extracellular fluid volume and blood pressure.

5. Overall Goal: To increase blood pressure and blood volume when they are low.

6. Regulation: Negative feedback: Increased BP/volume reduces stimuli for renin release. Atrial Natriuretic Factor (ANF) counteracts RAS.

7. Clinical Relevance:

ACE Inhibitors — (e.g., enalapril): Block ACE, reduce Angiotensin II, reduce BP.
Angiotensin Receptor Blockers (ARBs) — (e.g., losartan): Block Angiotensin II receptors, reduce BP.
Used in hypertension, heart failure, diabetic nephropathy.

Vyyuha Quick Recall

Really Active Agents Convert All Angiotensins Into Thirsty Salty People (RAACAAITS P)

Renin
Angiotensinogen
Angiotensin I
Converting Enzyme (ACE)
Angiotensin II
Aldosterone
Increased Thirst
Salty (Sodium retention)
Pressure (Increased blood pressure)